| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19216387
[patent_doc_number] => 20240181091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => ORAL DELIVERY OF SILICA/ALUMINOSILICATE NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/551786
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551786
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551786 | ORAL DELIVERY OF SILICA/ALUMINOSILICATE NANOPARTICLES | Mar 20, 2022 | Pending |
Array
(
[id] => 17865492
[patent_doc_number] => 20220288227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => Ultrasound Responsive Microbubbles And Related Methods
[patent_app_type] => utility
[patent_app_number] => 17/695612
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695612
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695612 | Ultrasound Responsive Microbubbles And Related Methods | Mar 14, 2022 | Pending |
Array
(
[id] => 19316918
[patent_doc_number] => 20240238458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/550964
[patent_app_country] => US
[patent_app_date] => 2022-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550964
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550964 | COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF | Mar 11, 2022 | Pending |
Array
(
[id] => 17655413
[patent_doc_number] => 20220175878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHOD FOR PREPARING EYE DROPS OF CYCLOSPORIN A
[patent_app_type] => utility
[patent_app_number] => 17/682094
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682094 | METHOD FOR PREPARING EYE DROPS OF CYCLOSPORIN A | Feb 27, 2022 | Pending |
Array
(
[id] => 18266010
[patent_doc_number] => 20230087252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => ANTI-TUMORAL COMPOUND AND RELATIVE PRODUCTION PROCESS
[patent_app_type] => utility
[patent_app_number] => 17/668272
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/668272 | ANTI-TUMORAL COMPOUND AND RELATIVE PRODUCTION PROCESS | Feb 8, 2022 | Abandoned |
Array
(
[id] => 17719101
[patent_doc_number] => 20220211820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => FUNGAL IRON ACQUISITION INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/583498
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583498 | Fungal iron acquisition inhibitors and uses thereof | Jan 24, 2022 | Issued |
Array
(
[id] => 18647937
[patent_doc_number] => 20230293720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Novel nanobubble that contains epilepsy medicine. The bubble polarizes in presence of the electric surge generated in the brain during an epilepsy attack and automatically discharges the medicine at the time and the site of the attack, stopping the seizure in its infancy without any external intervention. The bubble releases just enough medication into the bloodstream, significantly reducing side effects.
[patent_app_type] => utility
[patent_app_number] => 17/581366
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581366 | Novel nanobubble that contains epilepsy medicine. The bubble polarizes in presence of the electric surge generated in the brain during an epilepsy attack and automatically discharges the medicine at the time and the site of the attack, stopping the seizure in its infancy without any external intervention. The bubble releases just enough medication into the bloodstream, significantly reducing side effects. | Jan 20, 2022 | Abandoned |
Array
(
[id] => 19004956
[patent_doc_number] => 20240069027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => USE OF NITROGEN-DOPED CARBON FLUORESCENT QUANTUM DOT IN PREPARATION OF PRODUCT FOR DETECTING AEROBIC GLYCOLYSIS
[patent_app_type] => utility
[patent_app_number] => 18/035270
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035270
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035270 | USE OF NITROGEN-DOPED CARBON FLUORESCENT QUANTUM DOT IN PREPARATION OF PRODUCT FOR DETECTING AEROBIC GLYCOLYSIS | Dec 27, 2021 | Pending |
Array
(
[id] => 19297774
[patent_doc_number] => 20240226340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => METHOD FOR DETERMINING WHETHER AN IMMUNE RESPONSE HAS OCCURRED IN SUBJECTS WHO HAVE BEEN INFECTED WITH- OR VACCINATED AGAINST CORONAVIRUS
[patent_app_type] => utility
[patent_app_number] => 18/269243
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269243
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269243 | METHOD FOR DETERMINING WHETHER AN IMMUNE RESPONSE HAS OCCURRED IN SUBJECTS WHO HAVE BEEN INFECTED WITH- OR VACCINATED AGAINST CORONAVIRUS | Dec 22, 2021 | Pending |
Array
(
[id] => 17702946
[patent_doc_number] => 20220202952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => IMMUNOSTIMULATORY LIPOPLEX, PHARMACEUTICAL COMPOSITION INCLUDING IMMUNOSTIMULATORY LIPOPLEX, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/560820
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/560820 | IMMUNOSTIMULATORY LIPOPLEX, PHARMACEUTICAL COMPOSITION INCLUDING IMMUNOSTIMULATORY LIPOPLEX, AND USES THEREOF | Dec 22, 2021 | Abandoned |
Array
(
[id] => 17719164
[patent_doc_number] => 20220211883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => FAP-ACTIVATED RADIOTHERANOSTICS AND USES RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 17/554823
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554823 | FAP-ACTIVATED RADIOTHERANOSTICS AND USES RELATED THERETO | Dec 16, 2021 | Abandoned |
Array
(
[id] => 17790258
[patent_doc_number] => 20220249349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => MOISTURIZING COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/644215
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/644215 | MOISTURIZING COMPOSITIONS AND USES THEREOF | Dec 13, 2021 | Abandoned |
Array
(
[id] => 18404627
[patent_doc_number] => 20230165978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => Composition and A Method For Diagnosing And Treating Bacterial Infection
[patent_app_type] => utility
[patent_app_number] => 17/536193
[patent_app_country] => US
[patent_app_date] => 2021-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17536193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/536193 | Composition and A Method For Diagnosing And Treating Bacterial Infection | Nov 28, 2021 | Pending |
Array
(
[id] => 19396179
[patent_doc_number] => 12070508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Microparticles and nanoparticles having sulfate groups on the surface
[patent_app_type] => utility
[patent_app_number] => 17/534146
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23954
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/534146 | Microparticles and nanoparticles having sulfate groups on the surface | Nov 22, 2021 | Issued |
Array
(
[id] => 17655410
[patent_doc_number] => 20220175875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES
[patent_app_type] => utility
[patent_app_number] => 17/524211
[patent_app_country] => US
[patent_app_date] => 2021-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17524211
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/524211 | METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES | Nov 10, 2021 | Abandoned |
Array
(
[id] => 20415097
[patent_doc_number] => 12498375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Water-soluble compound for detection of beta-amyloid
[patent_app_type] => utility
[patent_app_number] => 17/520972
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/520972 | Water-soluble compound for detection of beta-amyloid | Nov 7, 2021 | Issued |
Array
(
[id] => 18348337
[patent_doc_number] => 20230136448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => Microbubble-extracellular vesicle complexes
[patent_app_type] => utility
[patent_app_number] => 17/517621
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517621
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517621 | Microbubble-extracellular vesicle complexes | Nov 1, 2021 | Issued |
Array
(
[id] => 17561804
[patent_doc_number] => 20220125953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => Synthetic Scaffolds for Metastasis Detection
[patent_app_type] => utility
[patent_app_number] => 17/516289
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17516289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/516289 | Synthetic Scaffolds for Metastasis Detection | Oct 31, 2021 | Abandoned |
Array
(
[id] => 17625442
[patent_doc_number] => 20220160457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => BIOPSY DEVICE MARKER AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/511864
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511864 | BIOPSY DEVICE MARKER AND RELATED METHODS | Oct 26, 2021 | Abandoned |
Array
(
[id] => 17546663
[patent_doc_number] => 20220118004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => TUNABLE IMMUNE RESPONSIVE BIODEGRADABLE ARGININE-BASED POLY(ESTER AMIDE)S AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/512124
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512124 | TUNABLE IMMUNE RESPONSIVE BIODEGRADABLE ARGININE-BASED POLY(ESTER AMIDE)S AND METHODS OF MAKING AND USING SAME | Oct 26, 2021 | Abandoned |